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Problems to Be Resolved in the
Management of Urticaria
Urticaria is one of the most common diseases, not
only for dermatologists and allergologists, but also
for primary care and many other medical practices. It
can be very severe and even fatal, especially in cases
of angioedema. However, many cases of urticaria are
easy to treat, spontaneously remit, and may even be
cured. On the other hand, it is difficult for us to an-
swer a question raised by many patients, “what is the
cause of my urticaria?”, regardless of their disease se-
verities and responsiveness to medications.
Diagnostic examinations may be useful for under-
standing the pathogenesis or for making a solid diag-
nosis, but these can be meaningless if performed
without specific aims based on careful clinical obser-
vations. Measurement of antigen-specific IgE is com-
monly used for the diagnosis and the management of
urticaria that has developed through type I allergy,
but is of little use for spontaneous urticaria. Skin bi-
opsy is essential for the diagnosis of urticarial vasculi-
tis, but unnecessary to know the cause of urticaria in-
duced by a systemic reaction against exogenous anti-
gen for type I allergy. Thus, it is important for physi-
cians to make a correct diagnosis of urticaria at the
level of subtypes. For this purpose, the role of guide-
lines for urticaria with a full classification system is
very important.
In 1997, the first urticaria guideline was published
by a committee of EAACI for the classification and di-
agnosis of physical urticarias.1 However, comprehen-
siveness, including treatments, is an important re-
quirement for an urticaria guideline. In this sense,
the first comprehensive guideline for urticaria was
published by Grattan, et al. in 2001 on behalf of Brit-
ish Association of Dermatologists (BAD).2 The Japa-
nese Dermatological Association (JDA) published its
first guideline for the diagnosis and treatment of urti-
caria and angioedema in 2005, and revised it in 2011.3
Also, the Japanese Association for Complement Re-
search published a guideline for the diagnosis and
treatment of hereditary angioedema (HAE) in 2010
on the website http:square.umin.ac.jpcompl
HAEHAEGuideline.html. Both of these Japanese
guidelines established or authorized most standard
diagnoses and treatments of urticaria and HAE in Ja-
pan, respectively. Principles of the treatment for urti-
caria and angioedema are most likely the same all
over the world. However, there are substantial differ-
ences in phenotypes, populations and responsiveness
between patients in Japan and those in Europe and
North America. Therefore, it is our great pleasure to
introduce these Japanese guidelines 4,5 for urticaria
and HAE, respectively, in this issue of Allergology In-
ternational in English. The guideline published by
JDA for the management of urticaria is unique in that
it covers almost the entire spectrum of urticaria and
angioedema and proposes a few comprehensive algo-
rithms for the management of spontaneous urticarias.
The option of medications is important, but the man-
ner of its usage is equally or even more important for
practices regarding the management of urticaria.
As causes of urticaria, foods6 and drugs7 are prob-
ably most frequently suspected by patients. In this is-
sue, two articles have reviewed these topics. A dra-
matic increase in the number of patients with wheat-
dependent exercise-induced anaphylaxis (WDEIA) in
Japan since 2010 has become a nation-wide problem
and has offered many important lessons and insights
not only to the medical community in Japan, but also
for our colleagues around the world. The develop-
ment of WDEIA in association with hydrolyzed wheat
protein has strongly suggested an important role of
the skin with respect to sensitization for type I al-
lergy. Moreover, the analysis of hypersensitivity of
these patients has revealed the importance of antigen
component analysis in food allergy.
The fifth topic in this issue is the role of hidrosis in
the pathogenesis of cholinergic urticaria. Historically,
this type of urticaria used to be included in the group
of physical urticarias. However, the above mentioned
recent guidelines for urticaria separate this urticaria
from physical urticarias. Cholinergic urticaria is cer-
tainly different from physical urticaria in that its
symptoms are induced by the stimuli that prompt
sweating, such as an increase in body temperature
and emotional excitations, which are not physical
stimuli. Bito et al.8 have reviewed recent progress in
the understanding of this unique urticaria, especially
concerning the aspect of acetylcholine and sweat al-
lergy. Certain populations of patients with this type of
urticaria may be associated with depressed sweating.
Interestingly, 26 out of 29 patients with cholinergic
urticaria and anhidrosis andor hypohidrosis in the
literature are Japanese. Another population of pa-
tients with cholinergic urticaria showed type I hyper-
sensitivity against their own sweat, either by skin test
andor in vitro basophil stimulation tests. Such pa-
tients may be treated by subcutaneous injections of
sweat antigens to induce tolerance. Molecular identi-
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fication of human sweat antigen is expected not only
to assist in the study of the pathogenesis, but also for
the development of new therapies for this unique and
often life disrupting subtype of urticaria.
Among 7 original articles and 1 letter to editor in
this issue, Izuhara’s group published two articles re-
garding periostin.9,10 Periostin is now widely recog-
nized to be an important biomarker for diagnosing as
to whether IL-13 or Th2 cells are highly involved in
asthma and allergic disease. This new cytokine was
originally found in microarray analysis done by these
authors several years ago. In this issue, they report
that periostin contributes to the pathogenesis of
atopic dermatitis by inducing TSLP production from
keratinocytes. Also, the same authors report that the
levels of periostin are increased in samples obtained
from allergic rhinitis and chronic sinusitis. We do
hope that readers of this issue find these articles in-
teresting and useful.
Michihiro Hide
Guest Editor, Allergology International
Hirohisa Saito
Editor-in-Chief, Allergology International
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